These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 25413277)

  • 1. RHOA inactivation enhances Wnt signalling and promotes colorectal cancer.
    Rodrigues P; Macaya I; Bazzocco S; Mazzolini R; Andretta E; Dopeso H; Mateo-Lozano S; Bilić J; Cartón-García F; Nieto R; Suárez-López L; Afonso E; Landolfi S; Hernandez-Losa J; Kobayashi K; Ramón y Cajal S; Tabernero J; Tebbutt NC; Mariadason JM; Schwartz S; Arango D
    Nat Commun; 2014 Nov; 5():5458. PubMed ID: 25413277
    [TBL] [Abstract][Full Text] [Related]  

  • 2. RhoA-ROCK and p38MAPK-MSK1 mediate vitamin D effects on gene expression, phenotype, and Wnt pathway in colon cancer cells.
    Ordóñez-Morán P; Larriba MJ; Pálmer HG; Valero RA; Barbáchano A; Duñach M; de Herreros AG; Villalobos C; Berciano MT; Lafarga M; Muñoz A
    J Cell Biol; 2008 Nov; 183(4):697-710. PubMed ID: 19015318
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Silencing RhoA inhibits migration and invasion through Wnt/β-catenin pathway and growth through cell cycle regulation in human tongue cancer.
    Yan G; Zou R; Chen Z; Fan B; Wang Z; Wang Y; Yin X; Zhang D; Tong L; Yang F; Jiang W; Fu W; Zheng J; Bergo MO; Dalin M; Zheng J; Chen S; Zhou J
    Acta Biochim Biophys Sin (Shanghai); 2014 Aug; 46(8):682-90. PubMed ID: 25001480
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanisms of inactivation of the tumour suppressor gene RHOA in colorectal cancer.
    Dopeso H; Rodrigues P; Bilic J; Bazzocco S; Cartón-García F; Macaya I; de Marcondes PG; Anguita E; Masanas M; Jiménez-Flores LM; Martínez-Barriocanal Á; Nieto R; Segura MF; Schwartz S; Mariadason JM; Arango D
    Br J Cancer; 2018 Jan; 118(1):106-116. PubMed ID: 29206819
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased diacylglycerol kinase ζ expression in human metastatic colon cancer cells augments Rho GTPase activity and contributes to enhanced invasion.
    Cai K; Mulatz K; Ard R; Nguyen T; Gee SH
    BMC Cancer; 2014 Mar; 14():208. PubMed ID: 24646293
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lovastatin Inhibits RhoA to Suppress Canonical Wnt/β-Catenin Signaling and Alternative Wnt-YAP/TAZ Signaling in Colon Cancer.
    Xiao Y; Liu Q; Peng N; Li Y; Qiu D; Yang T; Kang R; Usmani A; Amadasu E; Borlongan CV; Yu G
    Cell Transplant; 2022; 31():9636897221075749. PubMed ID: 35168393
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vitamin D and Wnt/beta-catenin pathway in colon cancer: role and regulation of DICKKOPF genes.
    Pendás-Franco N; Aguilera O; Pereira F; González-Sancho JM; Muñoz A
    Anticancer Res; 2008; 28(5A):2613-23. PubMed ID: 19035286
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Wnt5b promotes the cell motility essential for metastasis of oral squamous cell carcinoma through active Cdc42 and RhoA.
    Takeshita A; Iwai S; Morita Y; Niki-Yonekawa A; Hamada M; Yura Y
    Int J Oncol; 2014 Jan; 44(1):59-68. PubMed ID: 24220306
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rho GTPase activity modulates Wnt3a/beta-catenin signaling.
    Rossol-Allison J; Stemmle LN; Swenson-Fields KI; Kelly P; Fields PE; McCall SJ; Casey PJ; Fields TA
    Cell Signal; 2009 Nov; 21(11):1559-68. PubMed ID: 19482078
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gli1, downregulated in colorectal cancers, inhibits proliferation of colon cancer cells involving Wnt signalling activation.
    Akiyoshi T; Nakamura M; Koga K; Nakashima H; Yao T; Tsuneyoshi M; Tanaka M; Katano M
    Gut; 2006 Jul; 55(7):991-9. PubMed ID: 16299030
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Wnt/β-catenin/T-cell factor 4 pathway up-regulates high-mobility group A1 expression in colon cancer.
    Bush BM; Brock AT; Deng JA; Nelson RA; Sumter TF
    Cell Biochem Funct; 2013 Apr; 31(3):228-36. PubMed ID: 22961697
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Wnt secretion is required to maintain high levels of Wnt activity in colon cancer cells.
    Voloshanenko O; Erdmann G; Dubash TD; Augustin I; Metzig M; Moffa G; Hundsrucker C; Kerr G; Sandmann T; Anchang B; Demir K; Boehm C; Leible S; Ball CR; Glimm H; Spang R; Boutros M
    Nat Commun; 2013; 4():2610. PubMed ID: 24162018
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A diterpenoid derivative 15-oxospiramilactone inhibits Wnt/β-catenin signaling and colon cancer cell tumorigenesis.
    Wang W; Liu H; Wang S; Hao X; Li L
    Cell Res; 2011 May; 21(5):730-40. PubMed ID: 21321609
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Positive feedback regulation between phospholipase D and Wnt signaling promotes Wnt-driven anchorage-independent growth of colorectal cancer cells.
    Kang DW; Min do S
    PLoS One; 2010 Aug; 5(8):e12109. PubMed ID: 20711340
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Requirement of cell cycle and apoptosis regulator 1 for target gene activation by Wnt and beta-catenin and for anchorage-independent growth of human colon carcinoma cells.
    Ou CY; Kim JH; Yang CK; Stallcup MR
    J Biol Chem; 2009 Jul; 284(31):20629-37. PubMed ID: 19520846
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA-93 suppress colorectal cancer development via Wnt/β-catenin pathway downregulating.
    Tang Q; Zou Z; Zou C; Zhang Q; Huang R; Guan X; Li Q; Han Z; Wang D; Wei H; Gao X; Wang X
    Tumour Biol; 2015 Mar; 36(3):1701-10. PubMed ID: 25371073
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HEF1, a novel target of Wnt signaling, promotes colonic cell migration and cancer progression.
    Li Y; Bavarva JH; Wang Z; Guo J; Qian C; Thibodeau SN; Golemis EA; Liu W
    Oncogene; 2011 Jun; 30(23):2633-43. PubMed ID: 21317929
    [TBL] [Abstract][Full Text] [Related]  

  • 18. miR-574-5p negatively regulates Qki6/7 to impact β-catenin/Wnt signalling and the development of colorectal cancer.
    Ji S; Ye G; Zhang J; Wang L; Wang T; Wang Z; Zhang T; Wang G; Guo Z; Luo Y; Cai J; Yang JY
    Gut; 2013 May; 62(5):716-26. PubMed ID: 22490519
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NGX6 inhibits cell invasion and adhesion through suppression of Wnt/beta-catenin signal pathway in colon cancer.
    Guo Q; Shen S; Liao M; Lian P; Wang X
    Acta Biochim Biophys Sin (Shanghai); 2010 Jul; 42(7):450-6. PubMed ID: 20705583
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fusion of the BCL9 HD2 domain to E1A increases the cytopathic effect of an oncolytic adenovirus that targets colon cancer cells.
    Fuerer C; Homicsko K; Lukashev AN; Pittet AL; Iggo RD
    BMC Cancer; 2006 Oct; 6():236. PubMed ID: 17020613
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.